Editor's note - Page 8 of 19 - Express Pharma

Protect IP to grow GDP

Time for a policy push for pharma

Will NDA-2’s first budget be any different for the pharma sector?

A silver lining to withdrawal of GSP benefits?

Own up, course correct and move on

Post USTR Special 301 Report, pragmatism wins over confrontation?

India on USTR’s Priority ~ Watch List again

Cracking the cGMP code

Patient care apps serve a purpose, but need to be closely monitored

Stree Shakti in the CDSCO!